All participants in the prescription drug supply chain deserve scrutiny, but weakening the mechanisms that extract price concessions will not lower drug spending. The more likely outcomes are gains for drug companies and less efficient pharmacies, and higher drug costs. Effects will be especially felt by seniors on Medicare and by smaller employers that lack the leverage to offset the law’s new constraints.
Мужчина ворвался в прямой эфир телеканала и спустил штаны20:53
。业内人士推荐纸飞机下载作为进阶阅读
Pro: $200/month
Privacy isn't a feature — it's the foundation.